Human papillomavirus testing before elective supracervical hysterectomy.

Area of Science:

• Gynecologic Oncology
• Pathology
• Infectious Disease

Background:

• Cervical intraepithelial neoplasia (CIN) is a premalignant condition of the cervix.
• Supracervical hysterectomy involves the removal of the uterus while leaving the cervix intact.
• The management of the cervical stump in relation to HPV infection and subsequent CIN requires careful consideration.

Observation:

• A case of cervical intraepithelial neoplasia (CIN) occurring in the cervical stump is presented.
• This highlights a potential complication following supracervical hysterectomy.
• The presence of CIN in the stump indicates that the entire cervical epithelium may not be removed or may be susceptible to HPV infection.

Findings:

• Human papillomavirus (HPV) DNA testing can detect the presence of the virus, a primary cause of cervical cancer and its precursors.
• Preoperative HPV DNA testing may identify individuals at higher risk for developing CIN in the remaining cervical stump.
• This risk stratification can inform surgical decisions and patient counseling.

Implications:

• Identifying high-risk patients preoperatively allows for tailored surgical approaches and enhanced surveillance strategies.
• HPV DNA testing can improve preoperative counseling regarding the risks and benefits of supracervical hysterectomy versus total hysterectomy.
• Proactive screening and risk assessment can potentially reduce the incidence of post-hysterectomy CIN and improve patient outcomes.